# BVF Inc 13F holdings Q2 2026: $3.9 billion, 44 positions

BVF Inc reported $3.9 billion in 13F securities across 44 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Revolution Medicines Inc at $555 million, 14.2% of the reported value. Since Q1 2026 it opened 7 new positions and exited 4.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $3,910,995,502
- Positions: 44
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1056807
- Form 13F file number: 028-06800
- Business address: 44 Montgomery Street 40th Fl, San Francisco, CA 94104
- SEC filing: [0000921895-26-002163](https://www.sec.gov/Archives/edgar/data/1056807/000092189526002163/0000921895-26-002163-index.htm)

## Top 25 holdings by value

The largest of 44 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 2,965,160 | $555.3 million | +108,378 |
| [Kymera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kymera-therapeutics-inc-501575104) | COM | 3,872,052 | $444 million | -1,630,658 |
| [Xoma Royalty Corporation](https://specstream.ai/data/institutional-holders/xoma-royalty-corporation-98419j206) | COM NEW | 7,593,303 | $322.7 million | +5,003,000 |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 16,001,284 | $311.5 million | No change |
| [GH Research PLC](https://specstream.ai/data/institutional-holders/gh-research-plc-g3855l106) | ORDINARY SHARES | 8,650,158 | $232.5 million | No change |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 3,366,823 | $180.7 million | -92,535 |
| [Nektar Therapeutics](https://specstream.ai/data/institutional-holders/nektar-therapeutics-640268306) | COM NEW | 2,391,075 | $166.9 million | -168,520 |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 1,056,027 | $123.6 million | -528,700 |
| [Xencor Inc](https://specstream.ai/data/institutional-holders/xencor-inc-98401f105) | COM | 7,133,720 | $114.9 million | No change |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 2,154,704 | $112.9 million | +154,704 |
| [Monte Rosa Therapeutics Inc](https://specstream.ai/data/institutional-holders/monte-rosa-therapeutics-inc-61225m102) | COM | 4,460,886 | $108 million | No change |
| [Cullinan Therapeutics Inc](https://specstream.ai/data/institutional-holders/cullinan-therapeutics-inc-230031106) | COM | 5,750,683 | $104.7 million | No change |
| [Palvella Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/palvella-therapeutics-inc-ne-697947109) | COM | 672,789 | $102.8 million | -288,200 |
| [Zymeworks Inc](https://specstream.ai/data/institutional-holders/zymeworks-inc-98985y108) | COM | 3,649,142 | $95.4 million | -85,000 |
| [Kura Oncology Inc](https://specstream.ai/data/institutional-holders/kura-oncology-inc-50127t109) | COM | 8,445,769 | $92.7 million | No change |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 1,153,612 | $84.4 million | -118,700 |
| [Stoke Therapeutics Inc](https://specstream.ai/data/institutional-holders/stoke-therapeutics-inc-86150r107) | COM | 2,547,557 | $83.4 million | No change |
| [Olema Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/olema-pharmaceuticals-inc-68062p106) | COM | 5,295,893 | $66.3 million | No change |
| [Annexon Inc](https://specstream.ai/data/institutional-holders/annexon-inc-03589w102) | COM | 8,698,173 | $49.7 million | No change |
| [Crescent Biopharma Inc.](https://specstream.ai/data/institutional-holders/crescent-biopharma-inc-g2545c104) | COM | 2,748,763 | $49.5 million | No change |
| [Ac Immune SA](https://specstream.ai/data/institutional-holders/ac-immune-sa-h00263105) | SHS | 19,822,436 | $47.2 million | No change |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 1,476,196 | $47.1 million | -500,000 |
| [Sutro Biopharma Inc](https://specstream.ai/data/institutional-holders/sutro-biopharma-inc-869367201) | COM SHS | 1,251,788 | $41.6 million | No change |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 1,294,463 | $41.1 million | No change |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 2,075,545 | $38.4 million | +442,700 |

## New positions in Q2 2026

7 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Q32 Bio Inc](https://specstream.ai/data/institutional-holders/q32-bio-inc-746964105) | COM | 2,350,000 | $29.9 million |
| [Absci Corporation](https://specstream.ai/data/institutional-holders/absci-corporation-00091e109) | COM | 2,361,674 | $27.4 million |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 2,500,000 | $19.3 million |
| [Immunic Inc](https://specstream.ai/data/institutional-holders/immunic-inc-4525ep200) | COM NEW | 765,295 | $11.8 million |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 500,000 | $5.4 million |
| [Entera Bio LTD](https://specstream.ai/data/institutional-holders/entera-bio-ltd-m40527109) | SHS | 2,425,000 | $4.3 million |
| Engene Therapeutics Inc | \*W EXP 10/31/202 | 945,402 | $274,072 |

## Positions exited in Q2 2026

4 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 7,764,842 | $41.1 million |
| [Septerna Inc](https://specstream.ai/data/institutional-holders/septerna-inc-81734d104) | COM | 1,353,249 | $32.5 million |
| Immunic Inc | COM | 7,652,972 | $8.5 million |
| Engene Holdings Inc | \*W EXP 10/31/202 | 945,402 | $2.5 million |

## Also on SpecStream

- [BVF Inc Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1056807/000092189526002163/0000921895-26-002163-index.htm)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in San Francisco, California

- [Law firms in San Francisco, California](https://specstream.ai/data/businesses/law-firms/san-francisco-california-united-states)
- [Criminal defense law firms in San Francisco, California](https://specstream.ai/data/businesses/criminal-defense-law-firms/san-francisco-california-united-states)
- [Waste collection companies in San Francisco, California](https://specstream.ai/data/businesses/waste-collection-companies/san-francisco-california-united-states)
- [Pediatric clinics in San Francisco, California](https://specstream.ai/data/businesses/pediatric-clinics/san-francisco-california-united-states)
- [Home builders in San Francisco, California](https://specstream.ai/data/businesses/home-builders/san-francisco-california-united-states)
- [Broadcast media production companies in San Francisco, California](https://specstream.ai/data/businesses/broadcast-media-production-companies/san-francisco-california-united-states)
